O-linked GlcNAcylation (O-GlcNAcylation), a ubiquitous posttranslational modification on intracellular proteins, is dynamically regulated in cells. To analyze the turnover dynamics of O-GlcNAcylated proteins, we developed a quantitative time-resolved O-linked GlcNAc proteomics (qTOP) strategy based on metabolic pulse-chase labeling with an O-GlcNAc chemical reporter and stable isotope labeling with amino acids in cell culture (SILAC). Applying qTOP, we quantified the turnover rates of 533 O-GlcNAcylated proteins in NIH 3T3 cells and discovered that about 14% exhibited minimal removal of O-GlcNAc or degradation of protein backbones. The stability of those hyperstable O-GlcNAcylated proteins was more sensitive to O-GlcNAcylation inhibition compared with the more dynamic populations. Among the hyperstable population were three core proteins of box C/D small nucleolar ribonucleoprotein complexes (snoRNPs): fibrillarin (FBL), nucleolar protein 5A (NOP56), and nucleolar protein 5 (NOP58). We showed that O-GlcNAcylation stabilized these proteins and was essential for snoRNP assembly. Blocking O-GlcNAcylation on FBL altered the 2′-O-methylation of rRNAs and impaired cancer cell proliferation and tumor formation in vivo.
O-GlcNAcylation | metabolic labeling | proteomics | protein stability | snoRNP I n mammalian cells, a large number of nuclear, cytoplasmic, and mitochondrial proteins are posttranslationally or cotranslationally modified with a GlcNAc monosaccharide β-linked to serine or threonine residues, which is termed as O-linked GlcNAcylation (O-GlcNAcylation) (1, 2) . The O-GlcNAc modification has been implicated in a whole range of cellular processes, including transcriptional regulation (3), signal transduction (4), and stress response (5) . At the protein level, O-GlcNAcylation was found to regulate protein stability (6) (7) (8) (9) (10) and activity (11) (12) (13) (14) . Remarkably, a sole known enzyme O-linked GlcNAc transferase (OGT) catalyzes all cellular O-GlcNAc modifications (15, 16) . Another enzyme, O-linked GlcNAcase (OGA), can remove O-GlcNAc from modified proteins, making O-GlcNAcylation a reversible modification (17) . To date, the number of candidate O-GlcNAcylated proteins in mammalian cells has accumulated to more than 1,000, mainly owing to recent MS-based proteomic profiling in various cell lines (18) (19) (20) (21) (22) (23) (24) . Such a broad scope of protein substrates raises several interesting questions about O-GlcNAcylation. Are all of the protein O-GlcNAcylation events reversible in cells? Do O-GlcNAcylated proteins turn over at different rates? Is the stability of O-GlcNAylated proteins differentially affected by the modification?
To address these important questions, we sought to develop a quantitative time-resolved method for globally profiling the turnover dynamics of O-GlcNAcylated proteins in living cells. The MSbased O-GlcNAcome profiling has been largely facilitated by emerging methods for selective enrichment of O-GlcNAcylated proteins, such as affinity purification using O-GlcNAc-recognizing antibodies (19, 25) or lectins (20, 26) , and chemoenzymatic (21, 27) or metabolic labeling of O-GlcNAc with bioorthogonal chemical reporters followed by click labeling with affinity tags (23, (28) (29) (30) (31) . In contrast to most of the enrichment methods that are performed in vitro, metabolic incorporation of O-GlcNAc reporters enables chemical labeling of O-GlcNAc in living cells. Moreover, metabolic labeling is compatible with pulse-chase experiments (32) (33) (34) (35) , and therefore, chemical reporters of O-GlcNAc may potentially be exploited to measure the O-GlcNAcylation dynamics and turnover rates of O-GlcNAcylated proteins. However, proteomic studies based on O-GlcNAc chemical reporters have so far been performed using spectral counting, a semiquantitative method.
Herein, we describe a quantitative time-resolved O-linked GlcNAc proteomics (qTOP) strategy for global analysis of the turnover dynamics of O-GlcNAcylated proteins in living cells. The qTOP approach combines the strengths of two protocols: (i) the metabolic pulse-chase labeling with an O-GlcNAc chemical reporter in living cells, which enables time-resolved enrichment of O-GlcNAcylated proteins, and (ii) the stable isotope labeling with amino acids in cell culture (SILAC), which permits quantitative analysis of the enriched O-GlcNAc proteomes. Applying qTOP, we successfully quantified the degradation rates of 533 O-GlcNAcylated proteins in NIH 3T3 cells, which were categorized into three subgroups: "hyperstable," "dynamic," and "hyperdynamic," The hyperstable population accounted for an unexpectedly high portion (∼14%) of
Significance
In mammalian cells, more than 1,000 intracellular proteins are posttranslationally modified with O-linked GlcNAc (O-GlcNAc), which regulates many important biological processes. The O-GlcNAc modification has been found to dynamically cycle on and off the modified proteins. How O-GlcNAc affects protein stability remains to be investigated at the proteome level. In this work, we developed a quantitative time-resolved proteomic strategy to analyze the turnover dynamics of O-GlcNAcylated proteins. We discovered that not all protein O-GlcNAcylation events were reversible and that a subset of O-GlcNAcylated proteins exhibited minimal removal of O-GlcNAc or degradation of protein backbones. Our work reveals stable O-GlcNAc as an important regulatory mechanism for stabilizing proteins, such as core proteins of box C/D small nucleolar ribonucleoprotein complexes.
the O-GlcNAcyated proteome that we quantified. More importantly, those hyperstable O-GlcNAc modifications had more profound effects on stabilizing the modified proteins, among which were three core proteins of box C/D small nucleolar ribonucleoprotein complexes (snoRNPs)-fibrillarin (FBL), nucleolar protein 5A (NOP56), and nucleolar protein 5 (NOP58).
Box C/D snoRNPs consist of a box C/D small nucleolar RNA (snoRNA) and a set of four core proteins-FBL, NOP56, NOP58, and nonhistone chromosome protein 2-like 1 (NHP2L1; SNU13, 15.5K). They play an essential role in ribosome assembly by methylating rRNAs at the 2′-O-ribose with FBL as the methyltransferase (36) . In this work, qTOP revealed that FBL, NOP56, and NOP58 were modified with stable O-GlcNAc. We further characterized the functional consequences of O-GlcNAcylation for box C/D snoRNPs and showed that it played an important role in snoRNP assembly and biogenesis via stabilizing the modified core proteins and regulating their subnuclear localization and interactions. Furthermore, we identified a major O-GlcNAcylation site on FBL and found that O-GlcNAcylation of FBL regulated rRNA methylation patterns and promoted tumorigenesis.
Results

SILAC-Based Quantification Improves O-GlcNAcylated Proteome
Profiling. To establish the qTOP platform, we first implemented SILAC into the chemical reporter-based O-GlcNAc proteomic identification. Several GlcNAc and GalNAc analogs containing an azide or alkyne have been developed as O-GlcNAc chemical reporters, which showed varied efficiencies and specificities for O-GlcNAc labeling (23, 24, (28) (29) (30) (31) (Fig. S1 ). We chose peracetylated 6-azido-6-deoxy-GlcNAc (Ac 3 6AzGlcNAc) for this work, because it was shown to exclusively label O-GlcNAc without entering other glycosylation pathways and enabled identification of 366 O-GlcNAcylated proteins in NIH 3T3 cells by spectral counting (23) . NIH 3T3 cells grown in culture medium containing isotopically labeled "heavy" lysine and arginine or standard "light" medium were treated with 200 μM Ac 3 6AzGlcNAc for 36 h (Fig.  S2A) . In-gel fluorescence scanning of the light and heavy cell lysates reacted with alkyne-Cy5 via Cu(I)-catalyzed azide-alkyne cycloaddition (i.e., click chemistry) exhibited identical labeling patterns and intensities, indicating that metabolic incorporation of 6-azido-6-deoxy-GlcNAc (6AzGlcNAc) does not differentiate between light and heavy cells (Fig. S2B) . Furthermore, 6AzGlcNAc labeling was OGT-dependent (Fig. S2C) .
Because SILAC-based quantification has been previously used to improve the accuracy and sensitivity of palmitoylation proteomics using an alkyne-containing palmitic acid analog (33), we sought similar improvements for large-scale identification of O-GlcNAcylated proteins. We first tested the accuracy of SILAC quantification. The heavy and light isotope-labeled cell lysates were combined at a 1:1 ratio followed by reaction with alkynebiotin, streptavidin enrichment, and on-bead trypsin digestion. The resulting peptides were analyzed by liquid chromatography (LC)-MS/MS using the multidimensional protein identification technology (37) protocol (Fig. S2A ). Peptides were identified by ProLuCID (38) , and their light/heavy SILAC ratios were quantified using CIMAGE (39). The protein ratio was then quantified as the median ratio across all peptides assigned to a specific protein. The distribution of protein ratios had a mean of 0.99, accurately matching the dilution factor value (Fig. S2D) . We then applied the SILAC-based quantitative chemoproteomics to identify O-GlcNAcylated proteins by performing the labeling experiments with Ac 3 6AzGlcNAc as the chemical reporter ( Fig. 1A and Fig. S2E ). In the standard "forward" SILAC experiment, the light cells were treated with Ac 3 6AzGlcNAc as a reporter, and the heavy cells were treated with peracetylated GlcNAc (Ac 4 GlcNAc) as a control. We also performed a replicate "reverse" SILAC experiment, where the labeling order was switched (i.e., heavy with the reporter and light as the control) to increase the robustness and accuracy for quantitation. The 6AzGlcNAc-incorporated proteins were enriched and quantified against the control, which identified 1,139 and 1,451 O-GlcNAcylated proteins in the forward and reverse labeling experiments, respectively (Fig. S2F) ; 896 proteins were reciprocally enriched and quantified in both experiments ( Fig. 1B and Dataset S1). Reanalyzing the same datasets with the spectral counting method, we could identify 699 O-GlcNAcylated proteins, of which 634 overlapped with the SILAC quantification (Fig. 1C) . Notably, by implementing the SILAC quantification method, the Ac 3 6AzGlcNAc-based chemoproteomics identified an additional 262 O-GlcNAcylated proteins with low spectral counts in NIH 3T3 cells, such as AHNAK, GAK, and UBR4 (Fig. 1D) . These results show that SILAC quantification can significantly improve the accuracy and sensitivity of the chemical reporter-based O-GlcNAc proteomics.
Excluding those with uncharacterized cellular localizations, all of the O-GlcNAcylated proteins identified by Ac 3 6AzGlcNAc labeling possess intracellular domains accessible by OGT, in agreement with the high specificity of Ac 3 6AzGlcNAc for O-GlcNAc labeling (Fig. 1E) . We further validated the identified O-GlcNAcylated proteins using a chemoenzymatic method based on a mutant galactosyltransferase (Y289L GalT), which recognizes terminal GlcNAc moieties and allows for labeling of endogenous and natural O-GlcNAc with uridine diphosphate N-azidoacetylgalactosamine (UDP-GalNAz) in cell lysates (40, 41) . By preforming the forward and reverse Y289L GalT labeling followed by click reaction with alkyne-biotin, streptavidin enrichment, and LC-MS/MS analysis, a total of 1,272 O-GlcNAcylated proteins were identified (Fig. S2G) ; 754 proteins were identified in both Ac 3 6AzGlcNAc and Y289L GalT labeling, which were classified as high-confidence O-GlcNAcylated proteins (Fig. 1F ).
Quantitative Analysis of the Dynamics of O-GlcNAcylated Proteins by qTOP. Having established that Ac 3 6AzGlcNAc in combination with SILAC could quantify more than 750 O-GlcNAcylated proteins in NIH 3T3 cells that could also be verified by Y289L GalT labeling, we next integrated the pulse-chase protocol to construct the qTOP platform for profiling the turnover dynamics of O-GlcNAc proteome ( Fig. 2A and Fig. S3A ). Light and heavy cells were pulse labeled with Ac 3 6AzGlcNAc for 36 h to ensure sufficient metabolic incorporation of the chemical reporter (Fig.  S3B) . In a forward qTOP experiment, the heavy cells were immediately harvested after pulse labeling to serve as the reference at time of 0 h, and the light cells were chased with Ac 4 GlcNAc for another 12 h (Fig. 2A) . This chase time was optimized to ensure that significant O-GlcNAc turnover events can be observed, and there are still enough chemical reporters remaining for detection (Fig. S3C) . Similarly, a reverse replicate of qTOP was also performed, in which the pulse-labeled heavy cells were chased with Ac 4 GlcNAc (Fig. S3A) . After mixing and lysing the cells, 6AzGlcNAc-labeled proteins were enriched, analyzed by LC-MS/MS, and quantified between the chased and reference samples. The residual amount of the pulse-labeled fraction of individual proteins after 12 h was revealed by the qTOP ratio (chased vs. reference), with smaller ratios corresponding to faster turnover rates of O-GlcNAcylated proteins. By isolating 6AzGlcNAc-incorporated proteins, qTOP quantified exclusively the O-GlcNAcylated proteoform, avoiding interferences imposed by the unmodified fraction. Moreover, the turnover of O-GlcNAcylated proteins measured in qTOP could result from protein degradation and/or OGA-catalyzed removal of 6AzGlc-NAc from the pulse-labeled proteins (Fig. S3D) .
In three biological replicates, we acquired qTOP ratios for 533 of 754 high-confidence O-GlcNAcylated proteins ( Fig. S3E and Dataset S2), which were normally distributed at a mean of 0.74 with an SD of 0.17 (Fig. 2B ). The proteins were classified into three groups by ranking their qTOP ratios: hyperstable O-GlcNAcylated proteins with ratios > 0.91 (i.e., mean + SD), dynamic O-GlcNAcylated proteins with ratios ≤ 0.91 and ≥ 0.57 (i.e., mean -SD), and hyperdynamic O-GlcNAcylated proteins with ratios < 0.57 ( Fig. 2B and Dataset S2). Consistent with the general view that O-GlcNAc modifications are often rapidly reversible and dynamic (42) (43) (44) (45) , 86% of the O-GlcNAcylated proteins quantified in the qTOP experiments showed a dynamic turnover in 12 h. Meanwhile, it is also intriguing to observe that quite a significant portion (∼14%) of the O-GlcNAcylated proteins (i.e., 75 proteins in the hyperstable group) showed not only minimal degradation of the protein backbone but also, minimal removal of O-GlcNAc within 12 h, reflecting their stable nature with slow turnover dynamics.
Stable O-GlcNAc Modification Has a Profound Effect on Stabilizing
Proteins. Given that a number of proteins have been found to be stabilized by O-GlcNAc modification, such as SP1, p53, BMAL1/CLOCK, and nuclear pore complex protein 62 (NUP62) (2, 7-9), we asked whether the hyperstable O-GlcNAc revealed by qTOP contributes to the stability of those O-GlcNAcylated proteins. To answer this question, we used an OGT inhibitor, peracetylated 2-acetamido-2-deoxy-5-thio-D-glucopyranose (Ac 4 5SGlc-NAc) (46) , to globally lower the cellular level of O-GlcNAcylation and then measured changes of protein abundance by SILAC-based quantitative proteomic analysis (Fig. 3A) . Heavy NIH 3T3 cells were treated with 50 μM Ac 4 5SGlcNAc for 48 h, and light cells were treated with the DMSO control. After mixing and lysing the cells, 2,500 proteins were quantified with high confidence (i.e., at least twice in three biological replicates), and the heavy to light ratios indicated the changes of protein abundance on O-GlcNAcylation inhibition ( 3C ). On OGT inhibition, >80% of the hyperstable O-GlcNAcylated proteins exhibited SILAC ratios smaller than 1.0, indicating that their abundance was decreased when O-GlcNAcylation was inhibited, whereas the percentages were much lower (57 and 60%) in the dynamic and hyperdynamic populations, respectively (Fig. 3D) . Furthermore, the extent of decrease was significantly greater for the hyperstable O-GlcNAcylated proteins than the dynamic and hyperdynamic populations (the mean ratio of 0.89 for the hyperstable group vs. 0.98 for the dynamic group and 0.99 for the highly dynamic group). Collectively, these results suggest that stable O-GlcNAc has more profound effects on stabilizing proteins. The 75 hyperstable O-GlcNAcylated proteins are mainly associated with three biological processes, including transport, metabolic process, and RNA regulation (Fig. 2C ). Among the list of transportassociated proteins, nucleoporin NUP214, a nuclear pore complex component protein, exhibited no detectable protein degradation or removal of O-GlcNAc in the qTOP experiments (Fig. S3F) . Consistent with our hypothesis that stable O-GlcNAc stabilizes proteins, NUP214 was indeed reported to be stabilized by OGlcNAcylation previously (10) . When we looked into the stable OGlcNAcylated proteins that are associated with RNA regulation, we noticed that three of four core protein components of box C/D snoRNPs were among the list, which are FBL, NOP56, and NOP58 (Fig. 2D) . Given the functional importance of these proteins in regulating snoRNP assembly and biogenesis, we continued to investigate the impact of O-GlcNAcylation on their protein stability as well as functional consequences.
FBL, NOP56, and NOP58 all showed selective enrichment in SILAC-based identification of O-GlcNAcylated proteins in Ac 3 6AzGlc-NAc-labeled cells (Fig. 4A) . To further validate that they are bona fide O-GlcNAcylated proteins, each of three proteins was recombinantly expressed with a C-terminal Flag-His tandem tag in HeLa cells treated with Ac 4 GalNAz and immunoprecipitated to measure its labeling by the chemical reporter. We chose Ac 4 GalNAz here as the chemical reporter, because it enters the GalNAc salvage pathway to form UDP-GalNAz, which is interconverted with UDP-N-azidoacetylglucosamine (UDP-GlcNAz), and provides a much better O-GlcNAc labeling efficiency (24, 29) . Despite that Ac 4 GalNAz also labels cell surface glycans and therefore, complicates the global proteomic profiling, it would not interference with biochemical studies on individual immunoprecipitated O-GlcNAcylated proteins. The cell lysates were conjugated with alkyne-biotin and immunoprecipitated with an anti-His antibody. Western blotting with an antibiotin antibody showed that FBL, NOP56, and NOP58 were all modified with GlcNAz (Fig. 4B) . Furthermore, FBL, NOP56, and NOP58 were all identified in the Y289L GalTbased proteomics, confirming their modifications with nature GlcNAc on the endogenous proteins (Fig. S5A) .
We adapted a previously developed method based on a resolvable mass tag to quantify the O-GlcNAcylation stoichiometry on the endogenous FBL, NOP56, and NOP58 (47) . Cell lysates were treated with Y289L GalT and UDP-GalNAz to tag O-GlcNAc with azides, which were subsequently click labeled with an alkyne-functionalized PEG mass tag with the molecular weight of about 2,000 or 5,000 (alkyne-PEG 2k or alkyne-PEG 5k ) and resolved by SDS/PAGE. Western blotting with antibodies against FBL, NOP56, or NOP58 exhibited a shift of molecular mass attributed to O-GlcNAc moieties chemoenzymatically labeled with the PEG mass tag (Fig. 4C) . The O-GlcNAcylation stoichiometries were estimated by quantifying the relative band intensities of modified and unmodified proteins. Using the alkyne-PEG 2K , the stoichiometry of FBL O-GlcNAcylation was estimated to be 40%. The alkyne-PEG 5K resulted in a lower labeling of FBL O-GlcNAc, which was probably caused by higher steric hindrance of the larger PEG chain (Fig. S5B) . Because of the higher molecular weights, NOP56 and NOP58 are better separated in SDS/PAGE with the alkyne-PEG 5K tag, giving the estimated O-GlcNAcylation stoichiometries as 49 and 45%, respectively (Fig. 4C) . Because it is possible that the PEGylation reactions did not proceed to completion, the O-GlcNAcylation stoichiometries could be underestimated to some extent.
Our O-GlcNAc proteomic profiling identified FBL, NOP56, and NOP58, leaving NHP2L1 as the only box C/D snoRNP protein component that is not O-GlcNAcylated. To confirm this result, we further examined the O-GlcNAcylation state of NHP2L1 by using the Ac 4 GalNAz labeling and the PEG mass tag-based assays, both of which exhibited no detectable O-GlcNAc modification on NHP2L1 (Fig. S5C) .
We next attempted to identify the exact sites of O-GlcNAcylation on these proteins. Flag/His-tagged proteins were purified from HeLa cells and subjected to analysis by tandem MS with electron transfer dissociation (ETD) fragmentation to preserve the labile O-GlcNAc glycosidic linkage. The tandem ETD spectrum unambiguously identified serine-142 (S142) of FBL as a site of O-GlcNAcylation (Fig. 4D and Fig. S5D ). To further verify the O-GlcNAcylation on S142 of FBL, an S142A mutant of FBL, FBL S142A -Flag/His, was overexpressed in HeLa cells treated with Ac 4 GalNAz. The lysates were reacted with alkyne-biotin and immunoprecipitated with the anti-His antibody, and Western blotting with the antibiotin antibody showed significantly reduced GlcNAz labeling on FBL S142A (Fig. 4E) . Moreover, Western blotting with an O-GlcNAc-recognizing antibody RL2 detected a strong O-GlcNAylation signal on purified Flag/His-FBL in contrast to Flag/His-FBL S142A , confirming S142 as the major O-GlcNAc modification site of FBL (Fig. 4F) . Our attempts to identify O-GlcNAc modification sites on NOP56 and NOP58 using ETD MS were not successful.
O-GlcNAcylation Stabilizes Box C/D snoRNP Core Proteins. Next, we assessed whether O-GlcNAcylation regulates the expression levels of FBL, NOP56, and NOP58. The overall cellular level of O-GlcNAc was inhibited by the OGT inhibitor Ac 4 5SGlcNAc. Consistent with our proteomic quantification (Fig. 3D and Fig. S4B) , the abundance of all of these three proteins, as detected by Western blot analysis, was significantly diminished on deprivation of O-GlcNAc in a time-dependent manner ( Fig. 5A and Fig. S6 A-C) . Quantitative RT-PCR (qRT-PCR) analysis showed that the mRNA levels of FBL, NOP56, and NOP58 were not lowered on OGT inhibition (Fig. S6 E-G) , excluding the possibility of transcriptional regulation. By knocking down OGT with siRNA to reduce O-GlcNAcylation (Fig. S7A) , we also observed that the protein levels of FBL, NOP56, and NOP58 were greatly reduced with no apparent decrease in their mRNA levels (Fig. S7 B-D and F) .
To test whether the reduced protein level was owing to decreased protein stability on O-GlcNAc deprivation, the cells were treated with cycloheximide (CHX) to stop protein synthesis. The immunoblotting of FBL, NOP56, and NOP58 showed that protein degradation was significantly accelerated by inhibiting OGT either genetically (Fig. S7G) or pharmacologically ( Fig. 5B and Fig. S8 A-C) .
Interestingly, the protein level of NHP2L1 was also diminished by OGT inhibition (Fig. 5A and Fig. S6D ) and knockdown (Fig.  S7F) , whereas its mRNA level was not lowered (Figs. S6H and S7E) . Correlatively, the degradation of NHP2L1 was accelerated by OGT knockdown (Fig. S7G) and inhibition ( Fig. 5B and Fig. S8D ). Because NHP2L1 was not O-GlcNAc modified, we suspected that the whole box C/D snoRNP complex might be destabilized when one of the essential components was disrupted. We therefore knocked down FBL by siRNA, which as expected, resulted in down-regulation of NHP2L1 expression as well as the expression of NOP56 and NOP58 (Fig. S9) . Similar results were observed for siRNA knockdown of NOP56 or NOP58. Taken together, these results show that O-GlcNAc regulates the stability and integrity of box C/D snoRNP by stabilizing FBL, NOP56, and NOP58. Values represent means ± SD from three replicate experiments. *P < 0.05 (Student's t test); **P < 0.01 (Student's t test); ***P < 0.001 (Student's t test).
As exemplified by NHP2L1, it is possible that global deprivation of O-GlcNAc may indirectly affect the stability of certain proteins.
To rule out such an indirect effect for FBL, we used its S142A mutant to specifically assay the functional role of O-GlcNAylation on its stability without interference by O-GlcNAc on other proteins. Computational modeling by Rosetta (48) indicated that the S142A mutation did not cause significant perturbation to the protein structural stability (Fig. S10A) . Furthermore, FBL WT and FBL S142A were expressed in Escherichia coli, which does not have O-GlcNAc modification. The thermal shift assay on cell lysates showed that FBL S142A exhibited unaltered thermal stability compared with FBL WT , suggesting that S142 mutation itself does not cause protein instability (Fig. S10B) . We then transfected HeLa cells with equal amounts of plasmids of FBL S142A -Flag/His and FBL WT -Flag/His, respectively. Comparable mRNA levels were confirmed by qRT-PCR (Fig. S10C) . As expected, Western blot analysis showed that the protein expression level of FBL S142A -Flag/His was significantly lower and that the degradation rate was much faster than that of the WT FBL-Flag/His (Fig. 5C and Fig. S10D ). Furthermore, confocal fluorescence microscopy confirmed that the S142A mutation resulted in a decreased protein level of GFP-FBL in HeLa cells (Fig. S10 E and F) . Collectively, these results show that the stability of FBL was directly regulated by O-GlcNAcylation at S142.
O-GlcNAc Is Essential for Subcellular Location of FBL and Its Interactions
with Other Core Proteins. The box C/D snoRNP proteins are synthesized in the cytosol, imported into the nucleoplasm and Cajal bodies for assembly with box C/D RNAs, and then, transported to the nucleolus as the mature snoRNPs (49) . To investigate the effects of O-GlcNAcylation on the subcellular location of FBL, HeLa cells transiently expressing GFP-FBL or GFF-FBL S142A were visualized by immunofluorescence microscopy. Hoechst staining and immunofluorescence staining of endogenous NOP58 were used to delineate the boundaries of nucleus and nucleolus, respectively (Fig.  5D ). The distribution of FBL or FBL S142A in each subcellular region was quantified by GFP fluorescence intensity, which showed that both the overall expression level and the nucleolar/nuclear percentage of GFP-FBL S142A were significantly lower than those of GFP-FBL (Fig. 5E) . These results indicate that O-GlcNAc is important in regulating the subnuclear localization of FBL.
To assay how O-GlcNAcylation of FBL affects its interactions with other box C/D snoRNP core proteins, FBL S142A -Flag/His and FBL WT -Flag/His were expressed in HeLa cells and immunoprecipitated using the anti-Flag antibody. The FBL-interacting proteins were coimmunoprecipitated, and their abundance was compared by Western blot analysis. Starting with the same amount of FBL S142A -Flag/His and FBL WT -Flag/His, much less NOP56, NOP58, and NHP2L1 were coimmunoprecipitated with the mutant FBL than with the WT, indicating that loss of O-GlcNAcylation at S142 of FBL disrupted its interactions with core proteins of box C/D snoRNPs and the assembly of the mature complex (Fig. 5F ).
O-GlcNAc-Mediated Alteration of rRNA Methylation. Given that O-GlcNAcylation regulates the stability of C/D snoRNP core proteins, we assessed whether changes in the O-GlcNAc level may alter rRNA methylation, one of the key functions of the box C/D snoRNPs. The 5S, 18S, and 28S rRNAs from Ac 4 5SGlc-NAc-and DMSO-treated cells were isolated and digested into nucleosides. The relative amounts of methylated adenosine (Am) and methylated guanine (Gm) were quantified by LC-MS/MS (50). Our results showed that O-GlcNAcylation inhibition reduced methylation globally in rRNAs (Fig. 5G) . In addition, we analyzed the methylation level of five known methylation sites located in the 5S, 18S, and 28S rRNAs using a site-specific semiquantitative qRT-PCR-based method (51, 52) . Consistent with the global reduction of rRNA methylation, all of five sites were significantly less methylated in the Ac 4 5SGlcNAc-treated cells, where the overall O-GlcNAc level was decreased and the expression of FBL was repressed (Fig. 5H) . These results indicate that aberrant O-GlcNAcylation alters the rRNA methylation pattern, presumably through destabilizing core proteins and regulating the assembly and biogenesis of box C/D snoRNPs.
O-GlcNAcylation of FBL at S142 Facilitates Tumorigenesis. FBL overexpression has been implicated in tumorigenesis, probably through modulation of ribosome activity by altering rRNA methylation (52) (53) (54) . To investigate whether O-GlcNAcylation of FBL contributes to tumorigenesis, we stably expressed FBL or FBL S142A in MCF7 cancer cells, and in agreement with the previous results (52), overexpression of FBL in MCF7 cells significantly increased colony formation and cell proliferation (Fig. 6 A and B) . Mutation of the O-GlcNAcylation site at S142 completely abolished these effects, suggesting that O-GlcNAc modification is essential for the FBLpromoted colony formation and cell proliferation. In addition, overexpression of FBL but not FBL S142A protected MCF7 cells against the drug doxorubicin (Fig. 6C) . The impact of FBL O-GlcNAcylation on tumor growth was further investigated in vivo by using a xenograft mouse model. MCF7 cells stably expressing FBL or FBL S142A were injected into nude mice. Decreased tumor mass was observed in mice injected with FBL S142A -expressing cells compared with mice injected with FBL WT -expressing cells (Fig. 6D) . Taken together, these in vitro and in vivo results show that the hyperstable O-GlcNAcylation of FBL at Ser142, through maintaining the protein stability, promotes cancer cell proliferation and tumor formation.
Discussion
It is intriguing that over 1,000 proteins are O-GlcNAcylated by a single glycosyltransferase OGT. In this regard, oligosaccharyltransferase, an endoplasmic reticulum (ER) membrane protein complex that catalyzes the first step of protein N-linked glycosylation, is one of the few enzymes that have comparably broad protein substrates (55) . Although N-glycosylation is generally regarded as an irreversible modification for membrane-associated and -secreted proteins, O-GlcNAcylation is thought to be dynamically regulated by OGA in concerted with OGT. The level of O-GlcNAcylation fluctuates in response to the nutrient condition and cellular stress (5, (56) (57) (58) . However, whether OGA can remove O-GlcNAc from all modified proteins and whether the turnover dynamics is differentially regulated among O-GlcNAcylated proteins remain largely uninvestigated. In this study, we developed the qTOP platform that enables quantitative analysis of the turnover rates of O-GlcNAcylated proteins. Our analysis revealed a population of hyperstable O-GlcNAcylated proteins, with O-GlcNAcylation that is minimally perturbed within a 12-h timeframe. Moreover, we found that the abundance of those proteins carrying hyperstable O-GlcNAc is more susceptible to OGT inhibition than those in the dynamic and hyperdynamic populations. We, therefore, propose that the stable O-GlcNAc with slow turnover kinetics has important functional implications in regulating the stability of modified proteins.
Among the hyperstable O-GlcNAcylated proteins identified in this study are FBL, NOP56, and NOP58, three of the box C/D snoRNP core proteins. The assembly pathway of box C/D snoRNPs has been extensively studied, and various assembly factors, such as the HSP90/R2TP chaperone/cochaperone system, have been characterized (49) . However, posttranslational modifications (PTMs) of the core proteins and their functional roles in snoRNP biogenesis are rarely studied. Recent proteomic profiling identified NOP58 as a substrate of small ubiquitin-related modifier (SUMO), which promotes its high-affinity binding with snoRNAs (59, 60) . Moreover, SUMO modification of NOP58 seems to be regulated by flanking serine phosphorylation (60) . Our study reveals O-GlcNAcylation as another PTM that regulates snoRNP assembly and biogenesis through regulating the stability, subcellular location, and interactions of the core proteins. The extensive interplays between those PTMs are very possible and remain to be investigated.
Alteration of O-GlcNAcylation impacts the functions of box C/D snoRNPs. For example, we show that inhibition of O-GlcNAcylation impairs the rRNA methylation level and pattern. Altered rRNA methylation was reported to affect ribosome production and translation (52, 61) . Correlatively, ribosome proteins were also found to be modified with O-GlcNAc (62, 63). Together, O-GlcNAc has proven an important PTM for regulating ribosome biogenesis and functions.
Elevated O-GlcNAcylation has been found in various cancer types and emerged as a general feature of cancer (64) . Many of the O-GlcNAcylated proteins in cancer cells are associated with tumorigenesis. One mechanism through which O-GlcNAc contributes to tumorigenesis is to regulate activities of those proteins. For example, O-GlcNAcylation of phosphofructokinase 1 was found to block its kinase activity and increase glucose flux through the pentose phosphate pathway (PPP), which promoted cancer cell proliferation and tumor formation (12) . Conversely, O-GlcNAc modification could activate the rate-limiting enzyme of the PPP, glucose-6-phosphate dehydrogenase, thus increasing glucose flux through the PPP (14) . Alternatively, O-GlcNAcylation may stabilize proteins promoting tumorigenesis. The examples include c-MYC (65), FoxM1 (66) , and Snail1 (67) . In this work, we show that O-GlcNAcylation on box C/D snoRNP core proteins, particularly FBL, enhances the stability of box C/D snoRNPs, which impacts rRNA methylation and ribosome biogenesis. The dysregulation of ribosome biogenesis in cancer cells plays key roles in oncogenesis (68) . Therefore, our work provides another link between O-GlcNAc and tumorigenesis.
Metabolic labeling with chemical reporters, such as 6AzGlc-NAc, enables the pulse-chase experiments for dynamic profiling of O-GlcNAc, which is difficult to achieve by using other labeling methods. Notably, 6AzGlcNAc incorporation results in an unnatural alteration on O-GlcNAc. Although we show that the resulting O-6AzGlcNAc can be removed by OGA, it might be possible that it is removed at a different rate. Nevertheless, the O-GlcNAc dynamics and the effects on protein stability quantified by qTOP are validated by SILAC-based proteomic quantification of the protein abundance on OGT inhibition. In addition, functional studies on individual proteins were cross-validated by using methods detecting natural O-GlcNAc, such as chemoenzymatic labeling with Y289L GalT and an anti-O-GlcNAc antibody, in addition to the chemical reporter-based labeling.
Other than the cytoplasmic and nuclear O-GlcNAc modification, an EGF-specific O-GlcNAcylation was recently discovered to occur in the ER for several secreted proteins containing EGF domains (69, 70) . The modification is catalyzed by an ERlocalized EGF-specific O-GlcNAc transferase (EOGT). In this work, none of these EOGT-modified proteins were quantified in qTOP. Interestingly, a recent study detected and identified a GlcNAc modification on cysteine of a few proteins, suggesting the possible occurrence of S-GlcNAcylation (71). Because it was shown that S-GlcNAc was not cleaved by OGA, the fact that the Ac 3 6AzGlcNAc labeling is sensitive to OGA suggests that this particular chemical reporter mainly labels O-GlcNAc. Furthermore, we performed quantitative proteomics with the Y289L GalT labeling to ensure that those proteins analyzed with qTOP are indeed O-GlcNAcylated.
In conclusion, we present a chemoproteomic strategy for selective enrichment and quantitative analysis of O-GlcNAcylated proteins as well as their turnover profiles in living cells. The large number of O-GlcNAcylated proteins categorized with distinct turnover profiles provides a rich and valuable resource for better understanding the O-GlcNAc biology. However, it should be noted that the qTOP methodology currently does not differentiate the removal of O-GlcNAc modification from the degradation of modified proteins, and we, therefore, chose to focus on the hyperstable population where both the protein and the modification appear to be highly stable with slow turnover kinetics. For the dynamic and hyperdynamic populations, it is possible that O-GlcNAc turns over more rapidly than protein or vice versa. To further distinguish between those situations, we envision expansion of qTOP with multiplexed quantitative proteomics. Equally important is to develop effective methods for site-specific profiling of O-GlcNAcylation that can be integrated into qTOP, and this integration would ultimately enable detailed analysis for proteins bearing multiple O-GlcNAc modifications with different turnover kinetics.
Materials and Methods
Details are in SI Materials and Methods, which includes detailed methods for quantitative chemoproteomic profiling, fluorescence imaging, rRNA methylation quantification, quantitative real-time PCR, in-gel fluorescence, cell proliferation assay, and in vivo tumor xenografts. All animal experiments were performed in accordance with guidelines approved by the Institutional Animal Care and Use Committee of Peking University accredited by Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.
